Our latest work highlights how menopause alters insulin sensitivity and diabetes management, yet the intersection remains under-researched. This study explores how menopause stages impact diabetes outcomes.
This survey explores the impact of COVID-19 on diabetes management, revealing high concern, precautionary steps, and changes in work and daily routines.
Part 1 of dQ&A’s CGM Series charts the rapid global rise of continuous glucose monitoring (CGM) —why uptake is soaring, benefits for patients, and what’s next.
Our 10-year member journeys reveal a powerful window into the diabetes patient experience, showing advances and the challenges that still remain.
A recent patient-reported outcome (PRO) measurement found that reduced hypoglycemia awareness is common in both type 1 and type 2 diabetes.
Discover how self-recorded “diabetes diary” videos can provide researchers truer patient voices than in-person research.
dQ&A helps clients include robust patient-preference studies in FDA regulatory submissions, strengthening decisions that shape diabetes care.
dQ&A launches a new tracking study of Italians with type 1 and type 2 diabetes, capturing real-world insights on care, technology use, and daily challenges.
dQ&A was honored to participate in the 2019 ADA Scientific Sessions with five posters and an abstract highlighting our work.
